Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)
III期研究的病理反应：围手术期卡瑞利珠单抗联合利沃塞拉尼和化疗对比单纯化疗治疗局部晚期胃癌（DRAGON IV/CAP 05）
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00795
Li, Chen; Tian, Yantao; Zheng, Yanan; Yuan, Fei; Shi, Zheng; Yang, Lin; Chen, Hao; Jiang, Lixin; Wang, Xixun; Zhao, Ping; Zhang, Benyan; Wang, Zhenqiang; Zhao, Qun; Dong, Jianhong; Lian, Changhong; Xu, Sanrong; Zhang, Aimin; Zheng, Zhichao; Wang, Kang; Dang, Chengxue; Wu, Dan; Chen, Jian; Xue, Yingwei; Liang, Bo; Cheng, Xiangdong; Wang, Qian; Chen, Luchuan; Xia, Tao; Liu, Heli; Xu, Dazhi; Zhuang, Jing; Wu, Tao; Zhao, Xi; Wu, Wei; Wang, Hongzhi; Peng, Junsheng; Hou, Zhiguo; Zheng, Rongrong; Chen, Yuting; Yin, Kai; Zhu, Zhenggang
